{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:12:10Z","timestamp":1775063530286,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.vaccine.2011.12.112","type":"journal-article","created":{"date-parts":[[2012,1,9]],"date-time":"2012-01-09T20:31:30Z","timestamp":1326141090000},"page":"B46-B51","source":"Crossref","is-referenced-by-count":39,"special_numbering":"S2","title":["Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010"],"prefix":"10.1016","volume":"30","author":[{"given":"Claude-Roger","family":"Ouandaogo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e9n\u00e9 M.","family":"Yam\u00e9ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien V.K.","family":"Diomand\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassirou","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmata","family":"Ou\u00e9draogo-Traor\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoudou H.","family":"Djingarey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neh\u00e9mie","family":"Mbakuliyemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick L.F.","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"September (Suppl. 1)","key":"10.1016\/j.vaccine.2011.12.112_bib0005","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The Meningitis Vaccine Project","volume":"25","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.12.112_bib0010","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1377\/hlthaff.2011.0295","article-title":"Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa","volume":"30","author":"Bishai","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2011.12.112_bib0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"New Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.112_bib0020","first-page":"31","article-title":"Global Advisory Committee on Vaccine Safety, 3\u20134 December 2009","volume":"85","year":"2010","journal-title":"WER"},{"issue":"30","key":"10.1016\/j.vaccine.2011.12.112_bib0025","first-page":"285","article-title":"Global Advisory Committee on Vaccine Safety, 16\u201317 June 2010","volume":"85","year":"2010","journal-title":"WER"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.12.112_bib0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2105\/AJPH.73.7.795","article-title":"Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont","volume":"73","author":"Vogt","year":"1983","journal-title":"Am J Public Health"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.12.112_bib0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00006454-200208000-00013","article-title":"Pediatric sentinel surveillance of vaccine-preventable diseases in Italy","volume":"21","author":"Ciofi Degli Atti","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"September (Suppl. 1)","key":"10.1016\/j.vaccine.2011.12.112_bib0040","doi-asserted-by":"crossref","first-page":"A72","DOI":"10.1016\/j.vaccine.2007.04.045","article-title":"Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A\/C\/W135 polysaccharide vaccine in Burkina Faso","volume":"25","author":"Bentsi-Enchill","year":"2007","journal-title":"Vaccine"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2011.12.112_bib0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/hv.1.4.2018","article-title":"Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology","volume":"1","author":"P\u00f6llabauer","year":"2005","journal-title":"Hum Vaccin"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.12.112_bib0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2471\/BLT.07.048025","article-title":"Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data","volume":"86","author":"Destefano","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"April (15\u201316)","key":"10.1016\/j.vaccine.2011.12.112_bib0055","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.112_bib0060","series-title":"Supplementary information on vaccine safety. Part 2: background rates of adverse events following immunization","author":"WHO","year":"2000"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.112_bib0065","first-page":"99","article-title":"Unsafe injections","volume":"76","author":"Kane","year":"1998","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.112_bib0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.bmb.a011700","article-title":"Advances and challenges for the expanded programme on immunization","volume":"54","author":"Cutts","year":"1998","journal-title":"Br Med Bull"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.112_bib0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/422454","article-title":"Fever after immunization: current concepts and improved future scientific understanding","volume":"39","author":"Kohl","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"5-6","key":"10.1016\/j.vaccine.2011.12.112_bib0080","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Michael","year":"2004","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.12.112_bib0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1046\/j.1365-3156.2003.01030.x","article-title":"Malaria morbidity, treatment-seeking behaviour, and mortality in a cohort of young children in rural Burkina Faso","volume":"8","author":"M\u00fcller","year":"2003","journal-title":"Trop Med Int Health"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.12.112_bib0090","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00228-005-0053-3","article-title":"Surveillance of adverse effects during a vaccination campaign against meningitis C","volume":"61","author":"Laribi\u00e8re","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"October 45","key":"10.1016\/j.vaccine.2011.12.112_bib0095","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009\u2013January 31, 2010","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T06:51:35Z","timestamp":1543301495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":19,"alternative-id":["S0264410X11020731"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.112","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}